CRON
CRON
NASDAQ · Pharmaceuticals

Cronos Group Inc

$2.65
+0.01 (+0.38%)
As of May 9, 1:35 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,027.5% upside
Low Target $20.40
Average Target $29.88
High Target $34.19
Current Price $2.65
Current
$2.65
Target
$29.88
$20.40 $29.88 avg $34.19
Scenario Analysis
Bear Case
$20.40
669.8%
Low target
Base Case
$29.88
+1,027.5%
Avg target
Bull Case
$34.19
+1,190.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.66
-43.1% from high
52-Week Low
$2.54
+4.3% from low
Target vs 52W High
$29.88
+541.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%